| scholarly article | Q13442814 |
| P2093 | author name string | Armstrong D | |
| Bukowski RM | |||
| Hamilton TA | |||
| Tubbs R | |||
| Tannenbaum CS | |||
| Finke JH | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 927-932 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor | |
| P478 | volume | 161 |
| Q51742964 | A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma. |
| Q37176443 | A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense |
| Q37164093 | A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma |
| Q24804035 | A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis |
| Q97524615 | Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance |
| Q37189574 | An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells |
| Q36544900 | An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer |
| Q37409509 | Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs. |
| Q35642602 | Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides |
| Q28397726 | Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis |
| Q41911701 | CCL19 reduces tumour burden in a model of advanced lung cancer |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q37425437 | CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination |
| Q36676660 | CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? |
| Q36821243 | CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy |
| Q35008494 | CXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii |
| Q45931583 | CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. |
| Q37429985 | CXCL9: evidence and contradictions for its role in tumor progression |
| Q33646444 | CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung |
| Q35635259 | CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection |
| Q35842027 | Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q30435873 | Chemokines as therapeutic targets in renal cell carcinoma |
| Q40639404 | Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines. |
| Q42288675 | Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models. |
| Q36144696 | Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses |
| Q96128419 | Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration |
| Q35887319 | Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma. |
| Q38942567 | Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice |
| Q34289445 | Heparanase enhances myeloma progression via CXCL10 downregulation |
| Q33670036 | IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. |
| Q36724827 | Immunotherapy of cancer by IL-12-based cytokine combinations |
| Q35745538 | In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue |
| Q35558806 | Infections in Patients with Inherited Defects in Phagocytic Function |
| Q62735867 | Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms |
| Q34568835 | Interferon γ limits the effectiveness of melanoma peptide vaccines |
| Q37196059 | Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes |
| Q41906680 | Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy |
| Q79902450 | Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill |
| Q34646946 | Interleukin-7 Gene-Modified Dendritic Cells Reduce Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma |
| Q36926833 | Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions |
| Q36686824 | Networking the host immune response in Plasmodium vivax malaria |
| Q45484028 | Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection |
| Q36322686 | Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth |
| Q36152019 | Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy |
| Q36354265 | Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study |
| Q54264279 | Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12. |
| Q34644481 | Regulation of chemokine expression by antiinflammatory cytokines. |
| Q38221172 | Regulation of chemokine expression in the tumor microenvironment |
| Q34397096 | Regulation of tumor growth by IFN-gamma in cancer immunotherapy. |
| Q30426606 | Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer |
| Q24797335 | SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10 |
| Q42017582 | Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research. |
| Q36231607 | Stat1-independent regulation of gene expression in response to IFN-gamma |
| Q51705595 | Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity. |
| Q30300383 | TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10 |
| Q34155350 | TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines |
| Q33596060 | The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis |
| Q28388695 | The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects |
| Q99580578 | The targeted delivery of interleukin-12 to the carcinoembryonic antigen increases the intratumoral density of NK and CD8+ T cell in an immunocompetent mouse model of colorectal cancer |
| Q36389337 | Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines |
| Q36401336 | Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth |
| Q30438648 | gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells |
Search more.